Casticin induces growth suppression and cell cycle arrest through activation of FOXO3a in hepatocellular carcinoma
Authors:
Open Access
- 9 October 2012
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 29 (1) , 103-108
Abstract
Casticin, a polymethoxyflavone, has been reported to exert anticancer activities. The objectives of this study were to examine the molecular mechanisms by which casticin induces the growth inhibition and cell cycle arrest in human hepatocellular carcinoma (HCC) cells. The HCC cell lines Hep G2 and PLC/PRF/5 were cultured in vitro. The growth inhibitory effects of casticin were evaluated using clonogenic assays. The distribution of phases in the cell cycle was analyzed using flow cytometry (FCM) analysis with propidium iodide (PI) staining. Multiple molecular techniques, such as western blotting and gene transfection, were used to explore the molecular mechanisms of action. Our data demonstrated that casticin significantly inhibited cell viability and colony formation in HCC cells. Furthermore, it induced cell cycle arrest in the G2/M phase. Casticin inhibited phosphorylation of the FOXO3a protein and decreased the expression of FoxM1 and its downstream genes, such as cyclin-dependent kinase (CDK1), cdc25B and cyclin B and increased the expression of p27KIP1. Silencing of FOXO3a expression by small interfering RNA (siRNA) transfection clearly attenuated the inhibitory effects of casticin on FOXM1 expression and cell growth. Our findings provided clear evidence that casticin induces growth suppression and cell cycle arrest through inhibition of FOXO3a phosphorylation causing inactivation of FOXM1 in HCC cells.Keywords
This publication has 36 references indexed in Scilit:
- Casticin-induced apoptosis involves death receptor 5 upregulation in hepatocellular carcinoma cellsWorld Journal of Gastroenterology, 2011
- Forkhead box M1 transcription factor: A novel target for cancer therapyCancer Treatment Reviews, 2010
- 8-bromo-7-methoxychrysin-induced apoptosis of hepatocellular carcinoma cells involves ROS and JNKWorld Journal of Gastroenterology, 2010
- Cytotoxic effects of flavonoids against a human colon cancer derived cell line, COLO 201: A potential natural anti-cancer substanceCancer Letters, 2009
- FoxM1 is up‐regulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent on p27kip1The Journal of Pathology, 2009
- FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cellsMolecular Cancer Therapeutics, 2008
- The PI-3kinase pathway in hematopoietic stem cells and leukemia-initiating cells: A mechanistic difference between normal and cancer stem cellsBlood Cells, Molecules, and Diseases, 2008
- FOXOs, cancer and regulation of apoptosisOncogene, 2008
- Inhibition of PI3K/AKT and MEK/ERK pathways act synergistically to enhance antiangiogenic effects of EGCG through activation of FOXO transcription factorJournal of Molecular Signaling, 2008
- The mouse Forkhead Box m1 transcription factor is essential for hepatoblast mitosis and development of intrahepatic bile ducts and vessels during liver morphogenesisDevelopmental Biology, 2004